Biotalys (BTLS.BR) Stock Price

Biotalys Price

Euronext Brussels·CLOSED
1.62
​
Market closed

The consensus 12-month price target for Biotalys is 6.12 EUR, about 277.8% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Biotalys stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotalys business model & stock analysis

Biotalys NV develops sustainable crop protection products, including AGROBODY Foundry, which combines active ingredients with Agrobodies as formulation agents. The company offers protein-based biocontrol solutions targeting crop pests and diseases, with a product pipeline called EvocaTM addressing key agricultural threats. Biotalys provides tools to prevent crop loss, extend post-harvest protection, and reduce food waste through its BioFungicides, BioInsecticides, and BioBactericides product lines. The company generates revenue by selling its crop protection products to agricultural stakeholders, including farmers and agribusinesses seeking sustainable pest management solutions. AGROBODY Foundry and EvocaTM are key products driving sales, while BioFungicides, BioInsecticides, and BioBactericides form the core of its product portfolio. Biotalys focuses on delivering biocontrol solutions that tackle a wide range of crop pests and diseases, appealing to environmentally conscious agricultural sectors. Biotalys' business model centers on developing and commercializing bio-based crop protection technologies. Its product pipeline, including EvocaTM and the three biocontrol categories, targets the growing market for sustainable agricultural practices. The company monetizes its technology through direct sales of its branded products to end-users in the agricultural industry, emphasizing eco-friendly alternatives to conventional pesticides.

Frequently asked questions about Biotalys

9 analysts currently rate the Biotalys stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Biotalys to generate revenue of 13.24 M EUR and earnings per share of -0.43 EUR.

The Biotalys share (BTLS.BR) is listed on 4 stock exchanges, including: Frankfurt (86C.F), München (86C.MU).

The expected revenue of Biotalys is 13.24 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Biotalys is -15.97 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Biotalys is currently -3.81. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biotalys stock.

The price-to-sales ratio (P/S) of Biotalys is currently 4.59. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biotalys stock.

The Eulerpool Quality Score for Biotalys is 2/10.

The ISIN of Biotalys is BE0974386188. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Biotalys is A3CS50. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Biotalys is BTLS.BR. The ticker symbol is used to trade Biotalys shares on the stock exchange.

Fair ValueTerminal
1.41 EUR
Over-/UndervaluationTerminal
Fairly valued
Industry
Chemicals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website biotalys.com
Country
Belgium
Currency
EUR
Initial public offering
Jul 2, 2021
ISIN
BE0974386188
Cusip
B1R5HQ100
Market capitalization
60.86 M EURMicro Cap
52-Week Range
PEG
0.21
P/E ratio
P/Ee 2026
-3.81
P/Ee 2027
-5.14
P/Ee 2028
-6.98
P/S
P/Se
4.59
EV/EBIT
—
P/B Ratio
5.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-99.21 %
Last updated Oct 30, 2026, 3:19 PM

Biotalys Peer Group

Biotalys Ticker

BRUSSELS · BTLS.BRBRUSSELS · BTLS.BRFRANKFURT · 86C.FMUNICH · 86C.MU

Biotalys FIGI

BTLS:BB · BBG011F7ZJ77BTLSEUR:XH · BBG011KMXWT7BTLSEUR:XF · BBG011KMXWW3BTLSEUR:XE · BBG011KMXWY1BTLSEUR:XL · BBG011KMXX06BTLSEUR:XG · BBG011KMXX15BTLSEUR:XO · BBG011KMXX24BTLSEUR:XA · BBG011KMXX97BTLSEUR:XT · BBG011KMXXD2BTLSEUR:XW · BBG011KMXXG9BTLSEUR:XU · BBG011KMXXJ6BTLSEUR:XV · BBG011KMXXM2

All fundamentals and in-depth analysis of Biotalys

Our stock analysis for Biotalys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotalys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.